-
The Efficacy and Safety of an Indocyanine Green-Macroaggregated Albumin-Hyaluronic Acid Mixture (LuminoMark™) for Surgical Localization of Recurrent Thyroid Cancer Ann. Surg. Oncol. (IF 3.7) Pub Date : 2024-02-02 Seok-ki Kim, Jungirl Seok, Chang Yoon Lee, Chang Hwan Ryu, Sung Yong Choi, Seog Yun Park, Young Ki Lee, Yul Hwangbo, Eun Kyung Lee, You Jin Lee, Sohyun Park, Tae Sung Kim, Tae Hyun Kim, Junsun Ryu, Yuh-Seog Jung
-
Robotic Pancreatoduodenectomy in Portal Annular Pancreas Using a Hanging Maneuver with Indocyanine Green Fluorescence Imaging Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-06 Kosei Takagi, Tomokazu Fuji, Motohiko Yamada, Jiro Kimura, Kazuya Yasui, Yuzo Umeda, Toshiyoshi Fujiwara
-
Breast Cancer Incidence Among Asian American Women in New York City: Disparities in Screening and Presentation Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-06 Claire M. Eden, Georgia Syrnioti, Josh Johnson, Genevieve Fasano, Solange Bayard, Chase Alston, Anni Liu, Xi Kathy Zhou, Tammy Ju, Lisa A. Newman, Manmeet Malik
-
Breast Health Awareness: Understanding Health-Seeking Behavior in Western Kenya Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-04 Manisha B. Bhatia, Nicholas Kisilu, Stephen Kiptoo, Ivan Limenik, Emily Adaniya, Silvanus Kibiwot, Lucy Nanjala Wabende, Sally Jepkirui, Dorice Adhiambo Awuor, Jennifer Morgan, Patrick J. Loehrer, JoAnna L. Hunter-Squires, Naftali Busakhala
-
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS–HIPEC) Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-04 Yusuf Ciftci, Shannon N. Radomski, Fabian M. Johnston, Jonathan B. Greer
-
Physical Prehabilitation in Patients who Underwent Major Abdominal Surgery: A Comprehensive Systematic Review and Component Network Meta-Analysis Using GRADE and CINeMA Approach Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Claudio Ricci, Laura Alberici, Francesco Serbassi, Paolo Caraceni, Marco Domenicali, Carlo Ingaldi, Davide Giovanni Grego, Carlo Mazzucchelli, Riccardo Casadei
-
Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Merel A. Spiekerman van Weezelenburg, Maikel J. A. M. Bakens, Jean H. T. Daemen, Loeki Aldenhoven, Elisabeth R. M. van Haaren, Alfred Janssen, Yvonne L. J. Vissers, Geerard L. Beets, James van Bastelaar
-
Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Xu Huang, Dongxian Jiang, Zitao Jian, Zhaochong Zeng, Shumin Zhang, Hong Fan, Tiantao Sun, Han Tang, Yingyong Hou, Lijie Tan
-
Impact of Hepatic Pedicle Clamping on Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma: Stratified Analysis Based on Intraoperative Blood Transfusion Status. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Shi-Chuan Tang,Jia-Hao Xu,Yi-Fan Yang,Jia-Ning Shi,Kong-Ying Lin,Jie Kong,Xian-Ming Wang,Zhong-Qi Fan,Wei-Min Gu,Ya-Hao Zhou,Hong-Zhi Liu,Ying-Jian Liang,Feng Shen,Wan Yee Lau,Yong-Yi Zeng,Tian Yang
BACKGROUND Hepatic pedicle clamping (HPC) is frequently utilized during hepatectomy to reduce intraoperative bleeding and diminish the need for intraoperative blood transfusion (IBT). The long-term prognostic implications of HPC following hepatectomy for hepatocellular carcinoma (HCC) remain under debate. This study aims to elucidate the association between HPC and oncologic outcomes after HCC resection
-
ASO Author Reflections: Imaging-Guided Localization Does Not Improve the Performance of Tailored Axillary Surgery-Preplanned OPBC-03/TAXIS Substudy. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Martin Heidinger,Walter P Weber
-
ASO Visual Abstract: Major Intraoperative Complications During Minimally Invasive Esophagectomy. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 H Söderström,J Moons,P Nafteux,E Uzun,P Grimminger,M D P Luyer,G A P Nieuwenhuijzen,M Nilsson,M Hayami,S Degisors,G Piessen,H Vanommeslaeghe,E Van Daele,E Cheong,Ch A Gutschow,D Vetter,N Schuring,S S Gisbertz,J Räsänen
-
ASO Visual Abstract: Frailty Assessed by Clinical Frailty Scale is Associated with Prognosis After Esophagectomy. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Atsushi Morito,Kazuto Harada,Masaaki Iwatsuki,Yuto Maeda,Chishou Mitsuura,Tasuku Toihata,Keisuke Kosumi,Kojiro Eto,Shiro Iwagami,Yoshifumi Baba,Yuji Miyamoto,Naoya Yoshida,Hideo Baba
-
Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-30 Aradhya Nigam,Janet W Y Li,Megan Fiasconaro,Sabrina Lin,Marinela Capanu,David A Kleiman,Kelvin Memeh,Nitya Raj,Diane L Reidy-Lagunes,Brian R Untch
BACKGROUND The benefit of primary tumor resection in distant metastatic small bowel neuroendocrine tumors (SBNETs) is controversial, with treatment-based morbidity not well-defined. We aimed to determine the impact of primary tumor resection on development of disease-specific complications in patients with metastatic well-differentiated SBNETs. PATIENTS AND METHODS A retrospective analysis was performed
-
Medullary Thyroid Carcinoma: Why are One in Four Patients Treated Out of Concordance from the ATA Guidelines? Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-30 Thomas Szabo Yamashita,Elizabeth Gardner Grubbs
-
ASO Author Reflections: Surgical Middle Ground-Navigating the Intraoperatively Detected Incidental Suspicious Gallbladder Wall Thickening: "The Parray's Approach". Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-30 Amir M Parray
-
Conditional Relative Survival of Exocrine Pancreatic Cancer: A Population-Based Study. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-30 Mee Joo Kang,Johyun Ha,Hyeong Min Park,Sang-Jae Park,Kyu-Won Jung,Sung-Sik Han
BACKGROUND Adjusted prognostic information is important for treatment decisions, especially in elderly patients or survivors of exocrine pancreatic cancer (EPC). This study aims to investigate conditional relative survival (CS) rates and conditional probabilities of death in patients with EPC. METHODS Data of 77,975 individuals diagnosed with EPC between 1999 and 2019 were obtained from the Korea Central
-
ASO Author Reflections: Surgical Strategies for Pancreatic Body Cancers with Portal Vein Involvement: Distal Pancreatectomy or Pancreaticoduodenectomy? Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-30 Aya Maekawa,Atsushi Oba,Kojiro Omiya,Yosuke Inoue,Yu Takahashi
-
Stenosis in Esophageal Cancer: A Poor Prognostic Indicator. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-29 Henry Kwon,Andrew M Popoff
-
Robotic Enucleation of Pancreatic Head Insulinomas in Close Proximity to the Pancreatic Duct. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-28 Patricio M Polanco,John D Karalis,Andres A Abreu,Joshua Weis,Herbert J Zeh
BACKGROUND Insulinomas are rare pancreatic neuroendocrine tumors for which the main curative treatment is surgical resection. Enucleation is preferred over pancreatoduodenectomy to minimize morbidity and function loss.1 Robotic-assisted surgery offers improved versatility and less blood loss than laparoscopic surgery for pancreatic enucleation.2-4 Our video describes the technique for robotic enucleation
-
Pure Laparoscopic Anatomic Resection of Liver Segment 4 with Middle Hepatic Vein Involvement Using Indocyanine Green Fluorescence Staining. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-28 Yani Liu,Yufu Peng,Yonggang Wei
BACKGROUND Laparoscopic anatomic resection of liver segment 4 is a technically challenging operation, which is rarely reported owing to the difficulty of defining the demarcation of a hepatic segment 4 on a monitor.1 The portal territory staining method is technically feasible to identify tumors and segment boundaries during hepatectomy.2 Herein, we describe the laparoscopic hepatectomy of segment
-
Laparoscopic Colorectal Surgery with Anatomical Recognition with Artificial Intelligence Assistance for Nerves and Dissection Layers. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-28 Shunjin Ryu,Keisuke Goto,Yuta Imaizumi,Yukio Nakabayashi
BACKGROUND In digestive tract surgery, dissection of an avascular space consisting of loose connective tissue (LCT) appearing by countertraction improves oncological outcomes and reduces complications.1-3 Kumazu et al.4 described a deep learning approach that automatically segments LCT to help surgeons.4 During left colorectal surgery, lumbar splanchnic, hypogastric, and pelvic visceral nerve injuries
-
Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-28 Brendin R Beaulieu-Jones,Emily J Ha,Ann Fefferman,Judy Wang,Sophie H Chung,Jennifer F Tseng,Andrea Merrill,Teviah E Sachs,Naomi Y Ko,Michael R Cassidy
INTRODUCTION Initial treatment for nonmetastatic breast cancer is resection or neoadjuvant systemic therapy, depending on tumor biology and patient factors. Delays in treatment have been shown to impact survival and quality of life. Little has been published on the performance of safety-net hospitals in delivering timely care for all patients. METHODS We conducted a retrospective study of patients
-
ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Douglas S Swords,Timothy E Newhook,Ching-Wei D Tzeng,Nader N Massarweh,Yun Shin Chun,Sunyoung Lee,Ahmed O Kaseb,Mark Ghobrial,Jean-Nicolas Vauthey,Hop S Tran Cao
-
Association of ICD-10 Clinical Modification Codes for Social Determinants of Health with Surgical Outcomes and Hospital Charges Among Cancer Patients. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Adrian Diaz,Timothy Pawlik
INTRODUCTION We sought to characterize the impact of social determinants of health (SDOH)-related codes on outcomes among patients with a cancer diagnosis. METHODS Patients diagnosed with lung, pancreas, colon, or rectal cancer between 2017 and 2020 were identified in the California Department of Healthcare Access and Information Patient Discharge Database. Data on concomitant SDOH-related codes (International
-
Timing to Surgery and Lymph Node Upstaging in Gastric Cancer: An NCDB Analysis. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Maria Cristina Riascos,Jacques A Greenberg,Federico Palacardo,Rodrigo Edelmuth,V Colby Lewis,Anjile An,Haythem Najah,Hala Al Asadi,Parima Safe,Brendan M Finnerty,Paul J Christos,Thomas J Fahey,Rasa Zarnegar
BACKGROUND Prior studies have shown tumor specificity on the impact of longer time interval from diagnosis to surgery, however in gastric cancer (GC) this remains unclear. We aimed to determine if a longer time interval from diagnosis to surgery had an impact on lymph node (LN) upstaging and overall survival (OS) outcomes among patients with clinically node negative (cN0) GC. PATIENTS AND METHODS Patients
-
ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the Medtronic Synchromed II Pump for Intrahepatic Cancers. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Hannah G McDonald,Omar A Zaki,Matt J Wright,Rani Jayswal,Heidi Weiss,Rashmi T Nair,Halemane Ganesh,Scott Ellis,Jill M Kolesar,Jessica Moss,Mautin Barry-Hundeyin,Prakash K Pandalai,Joseph Kim,Reema A Patel,Michael J Cavnar
-
Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Meiyue Lou,Masaaki Iwatsuki,Xiyu Wu,Weiliyun Zhang,Chihiro Matsumoto,Hideo Baba
BACKGROUND The expression of programmed death-ligand 1 (PD-L1) in tumor cells is a leading cause of tumor immune escape; however, the precise mechanism underlying the regulation of PD-L1 expression in gastric cancer (GC) cells remains unknown. In this study, we aimed to investigate the potential mechanism of cancer-associated fibroblasts (CAFs) regulating PD-L1 expression in GC cells. METHODS We evaluated
-
Practical Prediction of New Baseline Renal Function After Partial Nephrectomy. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Nityam Rathi,Worapat Attawettayanon,Akira Kazama,Yosuke Yasuda,Carlos Munoz-Lopez,Kieran Lewis,Eran Maina,Andrew Wood,Diego A Palacios,Jianbo Li,Nour Abdallah,Christopher J Weight,Mohamed Eltemamy,Venkatesh Krishnamurthi,Robert Abouassaly,Steven C Campbell
BACKGROUND Partial nephrectomy (PN) is generally preferred for localized renal masses due to strong functional outcomes. Accurate prediction of new baseline glomerular filtration rate (NBGFR) after PN may facilitate preoperative counseling because NBGFR may affect long-term survival, particularly for patients with preoperative chronic kidney disease. Methods for predicting parenchymal volume preservation
-
Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Kjetil Søreide,Stefan Stättner,Julie Hallet
Small bowel neuroendocrine tumors (SB-NETs) are increasingly identified and have become the most frequent entity among small bowel tumors. An increasing incidence, a high prevalence, and a prolonged survival with optimal modern multidisciplinary management makes SB-NETs a unique set of tumors to consider for surgical oncologists. The major goals of surgical treatment in the setting of SB-NET include
-
ASO Author Reflections: Diversity of Cancer-Associated Fibroblasts Produced by Gastric Cancer Cells. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Kazunori Takahashi,Katsutoshi Shoda,Koichi Takiguchi,Daisuke Ichikawa
-
Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Hannah G McDonald,Omar A Zaki,Matt J Wright,Rani Jayswal,Heidi Weiss,Rashmi T Nair,Halemane Ganesh,Scott Ellis,Jill M Kolesar,Jessica Moss,Mautin Barry-Hundeyin,Prakash K Pandalai,Joseph Kim,Reema A Patel,Michael J Cavnar
BACKGROUND Discontinuation of the Codman 3000 pump in 2018 left no Food and Drug Administration (FDA)-approved hepatic artery infusion (HAI) device for unresectable colorectal liver metastases (uCLM) and intrahepatic cholangiocarcinoma (uIHC). Historically, HAI has been performed at academic medical centers in large metropolitan areas, which are often inaccessible to rural patients. Consequently, feasibility
-
ASO Author Reflections: Exploring the Best Parameter for Lymph Node Assessment in Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-25 Xu Huang,Lijie Tan
-
Update to ‘A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer’ Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Chase J. Wehrle, Masato Fujiki, Andrea Schlegel, Maureen Whitsett Linganna, Alejandro Pita, Jae-Keun Kim, David C. H. Kwon, Charles Miller, Koji Hashimoto, Svein Dueland, Kazunari Sasaki, Gonzalo Sapisochin, Pal-Dag Line, Roberto Hernandez-Alejandro, Federico Aucejo
Colorectal cancer is the second most common cause of cancer-related death worldwide, and half of patients present with colorectal liver metastasis (CRLM). Liver transplant (LT) has emerged as a treatment modality for otherwise unresectable CRLM. Since the publication of the Lebeck-Lee systematic review in 2022, additional evidence has come to light supporting LT for CRLM in highly selected patients
-
ASO Visual Abstract: Cancer Stem Cells of Esophageal Adenocarcinoma are Suppressed by Inhibitors of TRPV2 and SLC12A2. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Atsushi Shiozaki,Hiroyuki Inoue,Hiroki Shimizu,Toshiyuki Kosuga,Kenichi Takemoto,Michihiro Kudou,Takuma Ohashi,Tomohiro Arita,Hirotaka Konishi,Shuhei Komatsu,Takeshi Kubota,Hitoshi Fujiwara,Eigo Otsuji
-
Prognostic Factors and Outcomes in Elderly Esophagectomy Patients with Esophageal Cancer. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Peiyuan Wang,Mengxia Lei,Yujie Chen,Hao He,Junpeng Lin,Hui Lin,Wenwei Wei,Peng Chen,Derong Zhang,Weijie Chen,Hang Zhou,Pengqiang Gao,Shuoyan Liu,Feng Wang
BACKGROUND Choosing the appropriate treatment for elderly patients with esophageal cancer remains a contentious issue. While surgery is still a valid option, we aimed to identify predictors and outcomes in elderly esophagectomy patients with esophageal cancer. PATIENTS AND METHODS We analyzed characteristics, surgical outcomes, survival rates, cause-specific mortality, and recurrence in 120 patients
-
ASO Author Reflections: Advances in Minimally Invasive Liver Surgery: Laparoscopic Liver Tunnel for Challenging Tumor Localizations. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Roberto Lo Tesoriere,Alessandro Ferrero
-
Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Patrick L Wagner,Chelsea M Knotts,Vera S Donneberg,Neda Dadgar,Christian Cruz Pico,Kunhong Xiao,Ali Zaidi,Suzanne C Schiffman,Casey J Allen,Albert D Donnenberg,David L Bartlett
BACKGROUND OR PURPOSE Carcinomatosis, a distinct pattern of metastatic cancer in the peritoneal cavity, poses challenges for treatment and has limited therapeutic options. Understanding the immune environment of peritoneal surface malignancies is crucial for developing effective immunotherapeutic approaches. This study characterizes soluble immune mediators in the peritoneal fluid of patients with
-
Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer : Prognosis Prediction for Resectable GC. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Shaohua Guo,Erpeng Wang,Baishi Wang,Yonggan Xue,Yanshen Kuang,Hongyi Liu
BACKGROUND Prognostic models based on multiomics data may provide better predictive capability than those established at the single-omics level. Here we aimed to establish a prognostic model for resectable gastric cancer (GC) with multiomics information involving mutational, copy number, transcriptional, methylation, and clinicopathological alterations. PATIENTS AND METHODS The mutational, copy number
-
ASO Author Reflections: Effect of the Number of Examined Lymph Nodes on Survival in Gastric Signet-Ring Cell Cancer. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Yujuan Jiang,Xinxin Shao,Weikun Li,Haitao Hu,Yiming Lu,Yang Li,Yantao Tian
-
Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Shota Igaue,Ryoko Nozaki,Daichi Utsunomiya,Yuto Kubo,Kentaro Kubo,Daisuke Kurita,Shun Yamamoto,Koshiro Ishiyama,Junya Oguma,Ken Kato,Hiroyuki Daiko
BACKGROUND M1 esophageal carcinoma goes beyond localized disease and requires treatment with systemic therapy. M1 status is primarily divided into two categories: M1 lymph node metastasis and distant organ metastasis. Oligometastasis is defined as a state of limited metastatic disease, and surgery for oligometastasis of distant organs is reported to be beneficial in limited conditions. The aim of this
-
Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Gianluca Sampieri,Huaqi Li,Philopateer Ataalla,Kaitlyn Merriman,Christopher W Noel,Julie Hallet,Natalie Coburn,Irene Karam,Martin Smoragiewicz,Brian Wong,Rui Fu,Antoine Eskander
IMPORTANCE Collecting patient-reported outcomes (PROs) in routine cancer care improves patient-clinician communication, decision making, and overall patient satisfaction. Recommendations exist regarding standardized ways to collect, store, and interpret PRO data. However, evidence on incorporating PROs into cancer process of care, especially the type of HIs that are warranted after observing a concerning
-
ASO Author Reflections: Impact of Universal Germline Genetic Testing on Clinical Management in Rural Breast Cancer Patients. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-23 Charles Shelton,Sarah M Nielsen
-
A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 Anish J. Jain, Timothy E. Newhook, Elizabeth Lilley, Naruhiko Ikoma, Ching-Wei D. Tzeng, Yun Shin Chun, Jean Nicolas Vauthey, Hop S. Tran Cao
Establishment of inflow control and gentle effective retraction of the liver for optimal exposure are critical to safe hepatectomy. Multiple methods have been previously reported for inflow control in minimally invasive (MIS) hepatectomy including Huang’s Loop.1,2,3 We describe here the assembly and use of our modified version of Huang’s loop that permits adjustable, atraumatic, and totally intracorporeal
-
In Neoadjuvant FOLFIRINOX Chemotherapy for Pancreatic Ductal Adenocarcinoma, Which Response is the More Reliable Indicator for Prognosis, Radiologic or Biochemical? Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Won-Gun Yun, Youngmin Han, Young Jae Cho, Hye-Sol Jung, Mirang Lee, Wooil Kwon, Jin-Young Jang
-
Impact of Removal of Lymph Nodes on Survival in Stage I–III Gastric Signet-Ring Cell Cancer: The More, the Better? Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Yujuan Jiang, Xinxin Shao, Weikun Li, Haitao Hu, Yiming Lu, Yang Li, Yantao Tian
-
ASO Visual Abstract: Contralateral Prophylactic Mastectomy Decision Making-The Partners' Perspective. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Amanda L Nash,Diane L Bloom,Brittany M Chapman,Stephanie B Wheeler,Kandace P McGuire,Clara N Lee,Kevin Weinfurt,Donald L Rosenstein,Jennifer K Plichta,Julie C Jacobson Vann,E Shelley Hwang
-
ASO Visual Abstract: Variations in Travel Patterns Affect Regionalization of Complex Cancer Surgery in California. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Muhammad Musaab Munir,Yutaka Endo,Selamawit Woldesenbet,Joal Beane,Mary Dillhoff,Aslam Ejaz,Jordan Cloyd,Timothy M Pawlik
-
ASO Author Reflections: Neoadjuvant Therapy for Ampullary and Duodenal Adenocarcinoma-What Do We Know? Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Chunmeng Zhang,Bradley N Reames
-
ASO Author Reflections: Surgical Decision-Making in Adrenocortical Carcinoma: When Less is More. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Jesse E Passman,Heather Wachtel
-
Pre- and Post-treatment Double-Sequential-Point Dynamic Radiomic Model in the Response Prediction of Gastric Cancer to Neoadjuvant Chemotherapy: 3-Year Survival Analysis. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Yinkui Wang,Lei Tang,Xiangji Ying,Jiazheng Li,Fei Shan,Shuangxi Li,Yongning Jia,Kan Xue,Rulin Miao,Zhemin Li,Ziyu Li,Jiafu Ji
BACKGROUND Prognosis prediction of patients with gastric cancer after neoadjuvant chemotherapy is suboptimal. This study aims to develop and validate a dynamic radiomic model for prognosis prediction of patients with gastric cancer on the basis of baseline and posttreatment features. PATIENTS AND METHODS This single-center cohort study included patients with gastric adenocarcinoma treated with neoadjuvant
-
ASO Author Reflections: Classification of Intrahepatic Cholangiocarcinoma into Perihilar versus Peripheral Subtype. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Tao Wei,Xu-Feng Zhang,Timothy M Pawlik
-
ASO Author Reflections: Revolutionizing Oncologic Liver Surgery: The Laparoscopically Limited Anatomic Resections Odyssey. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-22 Taiga Wakabayashi,Go Wakabayashi
-
Educational Review: Clinical Application of Immune Checkpoint Blockade for the Treatment of Melanoma. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 David Su,Harriet Kluger,Kelly Olino
In the last decade, immunotherapy has become the cornerstone in the management of patients with melanoma, the foremost cause of skin-cancer-related death in the USA. The emergence of immune checkpoint blockade as a crucial element in current immunotherapy and combination strategies has significantly transformed the treatments of resectable and advanced (unresectable or metastatic) melanoma. This paper
-
Pancreatic Cancer Multidisciplinary Clinic is Associated with Improved Treatment and Elimination of Socioeconomic Disparities. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 Richard S Hoehn,Mazen Zenati,Caroline J Rieser,Lauren Stitt,Sharon Winters,Alessandro Paniccia,Amer H Zureikat
OBJECTIVE To identify the association between multidisciplinary clinic (MDC) management and disparities in treatment for patients with pancreatic cancer. BACKGROUND Socioeconomic status (SES) predicts treatment and survival for pancreatic cancer. Multidisciplinary clinics (MDCs) may improve surgical management for these patients. METHODS This is a retrospective cohort study (2010-2018) of all pancreatic
-
Prognostic Factors for Recovery from Left Recurrent Laryngeal Nerve Palsy After Minimally Invasive McKeown Esophagectomy: A Retrospective Study. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 Chun-Ting Kuo,Chien-Hung Chiu,Tuan-Jen Fang,Yin-Kai Chao
BACKGROUND Recurrent laryngeal nerve (RLN) palsy is a serious complication of esophagectomy that affects the patient's phonation and the ability to prevent life-threatening aspiration events. The aim of this single-center, retrospective study was to investigate the clinical course of left RLN palsy and to identify the main prognostic factors for recovery. METHODS The study cohort consisted of 85 patients
-
Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 Takashi Kanemura,Tomohira Takeoka,Takahito Sugase,Shinya Urakawa,Yasunori Masuike,Naoki Shinno,Hisashi Hara,Masatoshi Kitakaze,Masahiko Kubo,Yousuke Mukai,Toshinori Sueda,Shinichiro Hasegawa,Hirofumi Akita,Junichi Nishimura,Hiroshi Wada,Masayoshi Yasui,Takeshi Omori,Hiroshi Miyata
BACKGROUND The assessment of muscle mass loss, muscle strength, and physical function has been recommended in diagnosing sarcopenia. However, only muscle mass has been assessed in previous studies. Therefore, this study investigated the effect of comprehensively diagnosed preoperative sarcopenia on the prognosis of patients with esophageal cancer. METHODS The study analyzed 115 patients with esophageal
-
Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-21 Elad Sarfaty,Nazanin Khajoueinejad,Allen T Yu,Spiros Hiotis,Benjamin J Golas,Umut Sarpel,Daniel M Labow,Noah A Cohen
BACKGROUND Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) improves survival compared with chemotherapy alone in patients with peritoneal carcinomatosis (PC) of colorectal (CRC) origin, however, long-term survival data are lacking. We report the actual survival of patients who underwent CRS/HIPEC for PC of CRC origin with a minimum potential 5-year follow-up period to identify
-
ASO Visual Abstract: Results of Magnetic Resonance Imaging Screening in Patients at High Risk for Breast Cancer. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-12-01 Pabel A Miah,Nakisa Pourkey,Alyssa Marmer,Athanasios Sevdalis,Laura Fiedler,Charles DiMaggio,Linda Pak,Richard Shapiro,Karen Hiotis,Deborah Axelrod,Amber Guth,Freya Schnabel
-
Neoadjuvant Chemotherapy Improves Oncological Outcomes and Long-Term Survival Among Elderly Patients with Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis. Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-20 Karol Rawicz-Pruszyński,Yutaka Endo,Diamantis I Tsilimigras,Muhammad Musaab Munir,Vivian Resende,Alex Kim,Joal Beane,Zuzanna Pelc,Katarzyna Sędłak,Timothy M Pawlik
INTRODUCTION In the USA, approximately half of newly diagnosed patients with GC are 75 years or older. The objective of the current population-based study was to investigate the impact of neoadjuvant chemotherapy (NAC) on the outcomes of elderly patients with locally advanced GC. PATIENTS AND METHODS Patients aged > 75 years were identified from the National Cancer Database (NCDB). The primary outcome
-
Laparoscopic Liver Tunnel for Tumors at the Hepatocaval Confluence Ann. Surg. Oncol. (IF 3.7) Pub Date : 2023-11-19 Alessandro Ferrero, Roberto Lo Tesoriere, Rebecca Panconesi, Serena Langella, Andrea Pierluigi Fontana, Nadia Russolillo